HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 1,909-1,920 of 7,264
Drug study icon
CompletedNCT07101120

KH607 Tablets for depression

Official study title

A Phase 2, Two-Part (Open-Label Followed by Double-Blind) Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of KH607 in the Treatment of Adult Participants With Moderate or Severe Major Depressive Disorder

This study has finished and is no longer accepting participants.

In Beijing
DepressionMedication studyAges 18–65
Countries
China
Sponsor
Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Drug study icon
CompletedNCT06842992

A Phase II Study to Evaluate NH102 for Depression

What is this study about?

This study evaluated the safety and effectiveness of NH102 for people with depression.

This study has finished and is no longer accepting participants.

Multiple locations, including Hefei
DepressionMedication studyAges 18–65
Countries
China
Sponsor
Jiangsu Nhwa Pharmaceutical Co., Ltd.
Drug study icon
UnknownNCT03642964

A Study in people with Major Depressive Disorder

Official study title

A Phase 2a Study to Evaluate the Safety, Tolerability and Initial Efficacy of Pramipexole IR, Given With Ondansetron in Patients With Major Depressive Disorder

Current recruitment status is unconfirmed.

In Long Beach
DepressionMedication studyAges 18–65
Countries
United States
Sponsor
Chase Therapeutics Corporation
Drug study icon
CompletedNCT06792136

ONO-1110 in people with Major Depressive Disorder

What is this study about?

This study evaluated the safety and effectiveness of ONO-1110 for people with depression.

This study has finished and is no longer accepting participants.

Multiple locations, including Fukuoka
DepressionMedication studyAges 18–65
Countries
Japan
Sponsor
Ono Pharmaceutical Co., Ltd.
Drug study icon
CompletedNCT06796868

GW117 Tablets for depression

Official study title

A Multicenter, Randomized , Double-blind, Parallel, Placebo-controlled Design Clinical Trial of GW117 Tablets

This study has finished and is no longer accepting participants.

Multiple locations, including Baoding
DepressionMedication studyAges 18–65
Countries
China
Sponsor
Beijing Greatway Pharmaceutical Technology Co.,Ltd.
Drug study icon
CompletedNCT07193901

Safety study of Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray in depression

Official study title

A Randomized, Double-blind, Placebo-controlled Phase Il Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray in Patients With Depression and Acute Suicidal Ideation or Behavior

This study has finished and is no longer accepting participants.

Multiple locations, including Beijin
Depression, SuicidalityMedication studyAges 18–64
Countries
China
Sponsor
Sichuan Purity Pharmaceutical Technology Co., Ltd.
Drug study icon
CompletedNCT01701258

An Investigation of Early Life Stress and Depression

Official study title

Early Life Stress and Depression: Molecular and Functional Imaging Approaches

This study has finished and is no longer accepting participants.

Multiple locations, including Belmont
DepressionMedication studyAges 20–45
Countries
United States
Sponsor
Mclean Hospital (Hospital / academic medical center)
Other study type icon
Active Not RecruitingNCT05008198

Assessing an EEG Biomarker of Response to TMS for Major Depression

Official study title

Assessing an Electroencephalography (EEG) Biomarker of Response to Transcranial Magnetic Stimulation for Major Depression

This study is no longer accepting new participants.

In White River Junction
DepressionObservational studyAges 18+
Countries
United States
Sponsor
VA Office of Research and Development (Government agency)
Behavioral study icon
CompletedNCT04598906

Ecologically Valid Virtual Tasks vs Paper-pencil Methods in Cognitive Rehabilitation in people with Schizophrenia and Depression

Official study title

Comparison of the Effectiveness of the Virtual Environment in Cognitive Rehabilitation With Standard Rehabilitation Methods in Patients With Schizophrenia and in Patients With Major Depressive Disorder

This study has finished and is no longer accepting participants.

In Fryštát
Depression, SchizophreniaBehavioural studyAges 18–60
Countries
Czechia
Sponsor
National Institute of Mental Health, Czech Republic

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.